Financial giants have made a conspicuous bullish move on Amgen. Our analysis of options history for Amgen (NASDAQ:AMGN) revealed 8 unusual trades. Delving into the details, we found 37% of traders ...

Guggenheim trimmed its price target (PT) on Amgen (NASDAQ:AMGN) to $340 from $351 on Monday, May 4, while maintaining a Neutral rating. The revision follows the biotech’s Q1 2026 earnings release and ...

Amgen's pivot toward rare diseases showed promising momentum in late 2024. The company's specialized therapies generated $1.2 billion in third-quarter sales, highlighting the potential of recent ...

Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

MariTide Phase 3 studies to begin in first half of year FDA places hold on AMG 513 obesity drug trial Amgen's Q4 earnings beat estimates, revenue up 11% Feb 4 (Reuters) - Amgen (AMGN.O), opens new tab ...

A mgen will invest $900 million in an expansion of its Central Ohio biomanufacturing operations, bringing total investment in the state to over $1.4 billion. With the addition of 350 new jobs, the ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

Currently, Amgen pays $2.25 per share in dividends every quarter. Assuming no dividend cuts, investors can reasonably assume a forward annual dividend payment of $9 per share. With the Amgen stock ...